Mitochondrial defects in acute multiple sclerosis lesions
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis is a chronic inflammatory disease, which leads to focal plaques of demyelination and tissue injury in the CNS. The structural and immunopathological patterns of demyelination suggest that different immune mechanisms may be involved in tissue damage. In a subtype of lesions, which are mainly found in patients with acute fulminant multiple sclerosis with Balo's type concentric sclerosis and in a subset of early relapsing remitting multiple sclerosis, the initial myelin changes closely resemble those seen in white matter stroke (WMS), suggesting a hypoxia-like tissue injury. Since mitochondrial injury may be involved in the pathogenesis of such lesions, we analysed a number of mitochondrial respiratory chain proteins in active lesions from acute multiple sclerosis and from WMS using immunohistochemistry. Functionally important defects of mitochondrial respiratory chain complex IV [cytochrome c oxidase (COX)] including its catalytic component (COX-I) are present in Pattern III but not in Pattern II multiple sclerosis lesions. The lack of immunohistochemically detected COX-I is apparent in oligodendrocytes, hypertrophied astrocytes and axons, but not in microglia. The profile of immunohistochemically detected mitochondrial respiratory chain complex subunits differs between multiple sclerosis and WMS. The findings suggest that hypoxia-like tissue injury in Pattern III multiple sclerosis lesions may be due to mitochondrial impairment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Fig. 3 The oligodendrocytes, axons and hypertrophied astrocytes but not microglia lack COX-I immunoreactivity in Pattern III multiple sclerosis lesions. a–f: The left and right columns of images show COX-I and porin immunoreactivity, respectively. a and b: The double immunofluorescent labelling of COX-I (a, green) and oligodendrocyte marker, CNPase (a, red) identifies oligodendrocytes lacking COX-I immunoreactivity (a, arrowheads and insert) in the EA stage of Pattern III lesions. The cells with COX-I immunoreactivity in the EA stage lack CNPase immunoreactivity (a, arrow). In serial sections, CNPase (red) immunoreactive oligodendrocytes (b, arrowhead and insert) as well as numerous other cells in EA stage contain porin (green) immunoreactive elements. c and d: The double immunofluorescent labelling of COX-I (c, green) and axonal markers [phosphorylated (SMI31) and non-phosphorylated (SMI32) neurofilaments in red] identifies axons with only a small number of COX-I immunoreactive elements (c) in the LA stage of Pattern III lesions. In serial sections, the porin elements (d, green) are more numerous than COX-I elements (c, green) within demyelinated axons in the LA stage of Pattern III lesions. A confocal x–z image (d, insert) confirms the axonal location of the porin immunoreactive elements in the x–y images (d). e and f: The mitochondrial proteins [COX-I (e) and porin (f)] are co-stained with a astrocyte marker, glial fibrillarry acidic protein, using chromogens [DAB (brown) and Vector SG (grey), respectively]. The COX-I immunoreactive elements are absent in a proportion of hypertrophied astrocytes (e) in Pattern III lesions. The hypertrophied astrocytes in serial sections contain abundant porin immunoreactivity (f). g–i: In the LA stage of Pattern III lesions, the activated microglia distributed around the blood vessels and identified by the CD163 (h, red) immunoreactivity contain COX-I immunoreactivity (g and i, green). a–d: Confocal images. Scale bars = 10 µm (a–f) and 50 µm (g–i).](https://figures.cochat.ai/paper-figures/e37ad69935264b32a759bb0170581ea9/mitochondrial-defects-in-acute-multiple-sclerosis-lesions-figure-3.jpg)


![Fig. 6 The loss of mtDNA encoded respiratory chain subunit immunoreactivity in fixed brain tissue and implications for complex IV activity. (a–e) immunoreactivity in serial sections of fixed hippocampus. (f) activity of complexes II and IV in the snap frozen contralateral hippocampus. There are a number of cells containing complex II 70 kDa, a nuclear encoded subunit, immunoreactivity (a) in the CA2 layer of a fixed hippocampal section from a case with multiple deletions of mtDNA. In contrast, immunoreactivity for mtDNA encoded subunits [complex I 20 kDa or complex IV subunit I (COX-I)] is lacking in a proportion of cells, in serial sections (b and c, arrowheads and inserts). The cells lacking complex I 20 kDa or COX-I immunoreactivity (green) contain mitochondria (red) as shown by double immunofluorecent labelling with porin (d and e, arrowheads). The functional implications of the lack of COX-I immunoreactivity in fixed brain tissue can be clearly seen in a snap frozen section from the contralateral hippocampus where complex IV activity is lacking in a proportion of cells with complex II activity (f, blue).](https://figures.cochat.ai/paper-figures/9e7486509cba4887a953aac43c035355/mitochondrial-defects-in-acute-multiple-sclerosis-lesions-figure-6.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Oxidative damage and mitochondrial dysfunction are key features of MS pathology [277,278,279,280].”
From Ageing, Cellular Senescence and Neurodegenerative Disease (2018) · cites this paper as [279]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Other features common to both cuprizone-induced and type 3 MS lesions are mitochondrial stress, selective loss of myelin-associated glycoprotein (MAG), lesions with indistinct borders that are not perivascular, pronounced glial activation, and lymphocyte infiltration [43, 46, 65, 69–71].”
From Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination (2022) · cites this paper as [69]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitochondrial DNA mutations in human disease
Taylor, R. W., & Turnbull, D. M. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1606 · Cited by 1,852 · cited 5×
“…c oxidase Abbreviations: CNPase=cyclic nucleotide phosphodiesterase; COX=cytochrome c oxidase; LFB=Luxol fast blue; MAG=myelin associated glycoprotein; MBP=myelin basic protein; mtDNA=mitochondrial DNA; NO=nitric oxide; NWM=normal white matter; PLP=proteolipid protein; WMS=white matter stroke”
BackgroundMethodInfluentialSelf-citationMultiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740 · cited 1×
“Multiple sclerosis is an inflammatory demyelinating disease of the central nervous system with axonal degeneration and astrogliosis (Frohman et al., 2006).”
BackgroundMitochondrial Respiratory-Chain Diseases
DiMauro, S., & Schon, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022567 · Cited by 1,661 · cited 5×
“Keywords: multiple sclerosis; Pattern III lesion; mitochondria; cytochrome c oxidase Abbreviations: CNPase=cyclic nucleotide phosphodiesterase; COX=cytochrome c oxidase; LFB=Luxol fast blue; MAG=myelin associated glycoprotein; MBP=myelin basic protein; mtDNA=mitochondrial DNA; NO=nitric oxide;…”
BackgroundInfluentialvon Büdingen, H.-C., Palanichamy, A., Lehmann-Horn, K., Michel, B. A., & Zamvil, S. S. (2015) · European Neurology · doi:10.1159/000377675 · Cited by 1,463
Cleeter, M. W. J., Cooper, J. M., Darley-Usmar, V. M., Moncada, S., & Schapira, A. H. V. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00424-2 · Cited by 1,241 · cited 1×
“NO competitively inhibits the binding of oxygen to complex IV (Brown and Cooper, 1994; Cleeter et al., 1994).”
BackgroundHIF-1 Regulates Cytochrome Oxidase Subunits to Optimize Efficiency of Respiration in Hypoxic Cells
Fukuda, R., Zhang, H., Kim, J.-W., Shimoda, L., Dang, C. V., & Semenza, G. L. (2007) · Cell · doi:10.1016/j.cell.2007.01.047 · Cited by 1,225 · cited 5×
“Widespread defects of mitochondrial respiratory chain complexes inWMS lesions The transcription of mtDNA and nuclear DNA encoded subunits of the mitochondrial respiratory chain complexes are modulated by hypoxia (Vijayasarathy et al., 2003; Piruat and Lopez-Barneo, 2005; Fukuda et al., 2007).”
BackgroundInfluentialMicrodomains of Intracellular Ca2+: Molecular Determinants and Functional Consequences
Rizzuto, R., & Pozzan, T. (2006) · Physiological Reviews · doi:10.1152/physrev.00004.2005 · Cited by 1,206 · cited 1×
“Mitochondria also play an important role in apoptosis and calcium homeostasis (Rizzuto and Pozzan, 2006; Kalman et al., 2007).”
BackgroundRelapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,185 · cited 5×
“Mitochondrial defects in acute multiple sclerosis lesions Don Mahad,1 Iryna Ziabreva,1Hans Lassmann2 and DouglasTurnbull1 1The Mitochondrial Research Group, University of Newcastle uponTyne, UK and 2Centre for Brain Research, Medical University of Vienna, Austria Correspondence to: Prof. Dr Hans Lassmann, Center for B…”
BackgroundInfluentialBrown, G. C., & Cooper, C. E. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)01290-3 · Cited by 1,055 · cited 2×
“…c oxidase Abbreviations: CNPase=cyclic nucleotide phosphodiesterase; COX=cytochrome c oxidase; LFB=Luxol fast blue; MAG=myelin associated glycoprotein; MBP=myelin basic protein; mtDNA=mitochondrial DNA; NO=nitric oxide; NWM=normal white matter; PLP=proteolipid protein; WMS=white matter stroke”
BackgroundSystemic infections and inflammation affect chronic neurodegeneration
Perry, V. H., Cunningham, C., & Holmes, C. (2007) · Nature Reviews Immunology · doi:10.1038/nri2015 · Cited by 1,027 · cited 1×
“These activated microglia, found in close proximity to apoptotic oligodendrocytes, may release a range of mediators (Barnett and Prineas, 2004; Perry et al., 2007).”
Background
Cited by
Items 401–424 of 424
Metabolic treatments in murine models of multiple sclerosis
Alaeiilkhchi, N. (2023) · cIRcle (University of British Columbia) · doi:10.14288/1.0438320 · Cited by 1
Kieran, N. W., Suresh, R., Dorion, M.-F., MacDonald, A., Blain, M., Wen, D., Fuh, S.-C., Ryan, F., Diaz, R. J., Stratton, J. A., et al. (2022) · Figshare · doi:10.6084/m9.figshare.17982566
Li, S. (2015) · OhioLink ETD Center (Ohio Library and Information Network)
Kolić, I. (2021) · VinaR (Institute of Nuclear Sciences "Vinča")
Gene expression regulation in immune cell dysfunction in multiple sclerosis
Hrastelj, J. (2023) · ORCA Online Research @Cardiff (Cardiff University)
Junqueira, S. C. (2015) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Barrenechea, L. G. (2021) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Arrambide, G., & de Medicina, U. A. D. B. D. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Raafat, M. A., Al-Hasnaawei, S., Mousa, H. M., Malathi, H., Sahu, S., Prathiba, S., Singh, G., & Sinha, A. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70673
Hashem, M., Palset, A., Wu, Y., Hamilton, A. M., Wuerch, E. C., Yong, V. W., & Dunn, J. F. (2026) · Imaging Neuroscience · doi:10.1162/imag.a.1192
“Low totCCO could indicate abnormal mitochondria, fewer mitochondria per cell, or fewer living cells (G. Campbell & Mahad, 2018; Hatakeyama & Goto, 2017; D. Mahad et al., 2008).”
Madrigal‐Gamboa, V. (2024) · Investigative News in Education (Universidad de Costa Rica)
Kaddatz, H., Wenzel, L., Pril, E., Meien, S., Harz, V., Burkert, L., Behrangi, N., Zimmermann, A., Frintrop, L., Amor, S., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-03000-x
“The metabolic demands of myelin biogenesis and maintenance render oligodendrocytes highly susceptible to mitochondrial dysfunction and lipid peroxidation—central pathological features of cuprizone toxicity and active MS lesions [12, 36].”
Recherche de biomarqueurs biologiques de sclérose en plaques par protéomique quantitative
Hinsinger, G. (2016) · theses.fr (ABES) · doi:10.70675/c3081248z705dz4ac1z863cz8e0fb910cf85
Amri, F. (2016) · theses.fr (ABES) · doi:10.70675/42d94807zca99z426cz9a48z9145b88c6878
Physiopathologie et traitement de la fatigue dans la sclérose en plaques
Chalah, M. A. (2019) · theses.fr (ABES) · doi:10.70675/9be71a74z7578z4637za069zf44a656eb777
Dissecting the impact of cellular senescence on muscle regeneration
Cazin, C. (2020) · theses.fr (ABES) · doi:10.70675/42a7ff38zb338z4eb8za925z2ce0a01ee74e
Développement de peptides ciblant VDAC pour l’étude et le traitement de maladies démyélinisantes
Jacquard, M. F. (2023) · theses.fr (ABES) · doi:10.70675/33c8bd67z22cfz47b0zb14bz58b975b2f7d4
Exploring and Targeting the Connection of Iron and Copper Homeostasis to Neurodegenerative Diseases
Liu, X., Jia, L., Wu, K., Chen, M., Sun, J., Yang, C., Xu, C., Sun, J., Wang, J., & Dai, L. (2026) · MedComm · doi:10.1002/mco2.70766
Altered metabolism and endoplasmic reticulum-mitochondria contacts in multiple sclerosis neurons
Böse, C., Rehm, A., Wu, Z., Karl, A., Augustyniak, S., Renk, P., Salmen, A., Gold, R., Winklhofer, K. F., Gisevius, B., et al. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1915238
Metadata
- Authors
- Mahad, D., Ziabreva, I., Lassmann, H., & Turnbull, D.
- Affiliations
- Medical University of Vienna (AT)
- Corresponding author
- Lassmann, Hans
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-05-30
- Volume
- 131
- Issue
- 7
- Pages
- 1722-1735
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- PMC
- PMC2442422
- OpenAlex
- W2149715738
- Cited by
- 406
- References
- 50
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 22 · 2023: 18 · 2022: 33 · 2021: 25 · 2020: 30 · 2019: 26 · 2018: 13 · 2017: 23 · 2016: 25 · 2015: 28 · 2014: 28 · 2013: 30 · 2012: 24
- FWCI
- 15.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Brain (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Wellcome Trust (078415)
- Austrian Science Fund (P 19854)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- multiple sclerosis, mitochondrial dysfunction, cytochrome c oxidase, coxI, mitochondrial respiratory chain, Balo's concentric sclerosis, demyelination, oligodendrocytes, astrocytes, microglia, relapsing-remitting multiple sclerosis
- MeSH terms
- Acute Disease, Adult, Aged, Aged, 80 and over, Astrocytes, Axons, Diffuse Cerebral Sclerosis of Schilder, Electron Transport Complex IV, Electron Transport, Female, Humans, Male, Middle Aged, Mitochondria, Multiple Sclerosis, Oligodendroglia, Mitochondrial Encephalomyopathies, Mitochondrial Proteins, Mitochondrial Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.